IBDEI19D ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21376,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,21376,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,21377,0)
 ;;=G91.2^^84^949^23
 ;;^UTILITY(U,$J,358.3,21377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21377,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,21377,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,21377,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,21378,0)
 ;;=G30.8^^84^949^5
 ;;^UTILITY(U,$J,358.3,21378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21378,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,21378,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,21378,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,21379,0)
 ;;=G31.09^^84^949^16
 ;;^UTILITY(U,$J,358.3,21379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21379,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,21379,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,21379,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,21380,0)
 ;;=G20.^^84^949^24
 ;;^UTILITY(U,$J,358.3,21380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21380,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,21380,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,21380,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,21381,0)
 ;;=G20.^^84^949^25
 ;;^UTILITY(U,$J,358.3,21381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21381,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,21381,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,21381,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,21382,0)
 ;;=G31.01^^84^949^26
 ;;^UTILITY(U,$J,358.3,21382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21382,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,21382,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,21382,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,21383,0)
 ;;=G23.1^^84^949^28
 ;;^UTILITY(U,$J,358.3,21383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21383,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,21383,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,21383,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,21384,0)
 ;;=Z79.2^^84^950^1
 ;;^UTILITY(U,$J,358.3,21384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21384,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,21384,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,21384,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,21385,0)
 ;;=Z79.01^^84^950^2
 ;;^UTILITY(U,$J,358.3,21385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21385,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,21385,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,21385,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,21386,0)
 ;;=Z79.02^^84^950^3
 ;;^UTILITY(U,$J,358.3,21386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21386,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,21386,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,21386,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,21387,0)
 ;;=Z79.82^^84^950^4
 ;;^UTILITY(U,$J,358.3,21387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21387,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,21387,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,21387,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,21388,0)
 ;;=Z79.4^^84^950^5
 ;;^UTILITY(U,$J,358.3,21388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21388,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,21388,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,21388,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,21389,0)
 ;;=Z79.1^^84^950^7
 ;;^UTILITY(U,$J,358.3,21389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21389,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,21389,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,21389,2)
 ;;=^5063332
